HXT10 Antibody

What is HXT10 and what experimental applications are HXT10 antibodies suited for?

HXT10 is one of 17 hexose transporter genes in Saccharomyces cerevisiae, contributing to glucose uptake and metabolic regulation. The protein is encoded by the HXT10 gene (UniProt: P43581) and plays a specific role in yeast glucose transport systems .

HXT10 antibodies are particularly valuable for these experimental applications:

When selecting an HXT10 antibody, researchers should prioritize those validated for their specific application, particularly those purified by antigen-affinity methods, as these typically offer higher specificity for yeast membrane proteins .

How should I validate an HXT10 antibody before using it in my experiments?

Comprehensive validation is critical for ensuring reliable experimental results with HXT10 antibodies. Follow this methodological workflow:

• Positive and negative controls testing:

  • Positive control: Wild-type S. cerevisiae expressing native HXT10

  • Negative control: hxt10Δ knockout strains

  • Expected outcome: Signal in wild-type, absence in knockout

• Specificity testing against related HXT proteins:

  • Cross-reactivity assessment with other hexose transporters, particularly HXT5 and HXT8

  • Consider testing against HXT6, HXT15, HXT12, HXT1, HXT4 which share sequence homology

• Application-specific validation:

  • For Western blot: Verify expected molecular weight (~65kDa) and band pattern

  • For immunofluorescence: Confirm expected membrane localization pattern

  • For flow cytometry: Establish proper gating using hxt10Δ controls

• Batch-to-batch consistency assessment:

  • Compare new antibody lots with previously validated material

  • Document standard curves and detection limits for quantitative applications

Research indicates that insufficient validation of antibodies is a major source of irreproducible results in yeast protein research . Complete validation ensures experimental rigor and reliable data interpretation.

How can HXT10 antibodies help elucidate glucose transport regulation during metabolic stress?

HXT10 expression is glucose-repressed (GR), with β-galactosidase activity decreasing from 13 units (5% glycerol) to 0.8 units (4% glucose), indicating a 16-fold repression under high glucose conditions. HXT10 antibodies can be leveraged to investigate this regulation through several methodological approaches:

Methodology for studying stress-induced expression:

• Quantitative Western blot analysis:

  • Subject yeast cultures to various stressors (oxidative, osmotic, nutrient deprivation)

  • Harvest cells at defined timepoints (0, 15, 30, 60, 120 minutes)

  • Prepare membrane protein fractions using detergent extraction

  • Quantify HXT10 protein levels relative to membrane protein controls

  • Expected outcome: Differential expression patterns correlating with stress intensity and type

• Co-immunoprecipitation coupled with mass spectrometry:

  • Use HXT10 antibodies to pull down protein complexes under different metabolic conditions

  • Identify regulatory binding partners that modulate HXT10 activity

  • Analysis should include phosphorylation status assessment

  • This approach has successfully identified stress-responsive regulators of other hexose transporters

• Chromatin immunoprecipitation (ChIP) with transcription factor antibodies:

  • Combine with HXT10 expression analysis to correlate transcriptional regulation with protein levels

  • Important: Include histone modification analysis to assess epigenetic regulation

Recent research has shown that genipin treatment affects glucose metabolism, with significant upregulation of HXT10 expression occurring during nutrient stress and α-synuclein-induced toxicity . This finding suggests HXT10's involvement in cellular adaptation to proteotoxic stress.

What techniques can differentiate between HXT10 and other hexose transporters in yeast samples?

Distinguishing HXT10 from other highly homologous hexose transporters requires sophisticated methodological approaches:

Epitope targeting strategy:
Generate or select antibodies targeting unique regions of HXT10 that differ from other HXT proteins. The N-terminal and C-terminal regions typically show greater sequence divergence than the transmembrane domains and provide better specificity.

Recommended analytical protocols:

• Sequential immunoprecipitation:

  • First deplete samples using antibodies against major HXT proteins (HXT1, HXT2)

  • Then perform specific immunoprecipitation for HXT10

  • Validate using mass spectrometry to confirm target identity

• Competitive ELISA:

  • Pre-incubate antibody with recombinant fragments of various HXT proteins

  • Measure binding inhibition to quantify cross-reactivity

  • Establish concentration-dependent inhibition curves for specificity assessment

• Two-dimensional Western blotting:

  • Separate proteins by isoelectric point and molecular weight

  • HXT10 can be distinguished from other transporters by its unique spot pattern

  • Follow with mass spectrometry confirmation of identified spots

Research has demonstrated that even closely related proteins like HXT10 and HXT15 can be distinguished with proper antibody selection and optimization of detection conditions .

What are the optimal fixation and permeabilization methods for immunocytochemistry with HXT10 antibodies?

Membrane proteins like HXT10 require specific fixation and permeabilization protocols to preserve structure while allowing antibody access. Based on research methodologies for yeast membrane proteins:

Optimal fixation protocol:

• Chemical fixation options:

  • Primary recommendation: 3.7% formaldehyde for 30 minutes at room temperature

  • Alternative: 2% paraformaldehyde with 0.2% glutaraldehyde for improved membrane preservation

  • Avoid methanol fixation which can disrupt membrane protein epitopes

• Cell wall digestion (critical for yeast):

  • Prepare spheroplasts using lyticase (100 U/mL) treatment for 10-15 minutes at 30°C

  • Monitor cell wall digestion by measuring OD reduction (should decrease by 80-90%)

  • Stop reaction with cold PBS containing 1M sorbitol as osmotic stabilizer

• Permeabilization options:

  • For transmembrane domain epitopes: 0.1% Triton X-100 for 5 minutes

  • For cytoplasmic epitopes: 0.5% Triton X-100 for 10 minutes

  • For extracellular domain epitopes: Avoid detergent permeabilization

• Blocking considerations:

  • Use 3% BSA supplemented with 0.1% saponin to maintain membrane permeabilization

  • Include 5% normal serum from the same species as the secondary antibody

  • Allow minimum 1-hour blocking at room temperature

This methodology has been shown to optimize signal-to-noise ratio while preserving the native membrane localization of hexose transporters. Researchers studying protein trafficking should note that strong permeabilization may lead to extraction of membrane proteins from their native locations .

How can epitope mapping be performed to characterize the binding sites of HXT10 antibodies?

Understanding the precise epitope recognized by an HXT10 antibody is crucial for interpreting experimental results, especially when studying protein conformation or interaction domains. The following methodological approaches are recommended:

Systematic epitope mapping protocols:

• Peptide array analysis:

  • Synthesize overlapping peptides (12-15 amino acids) covering the entire HXT10 sequence

  • Spot peptides onto cellulose membranes

  • Probe with the HXT10 antibody of interest

  • Detect binding using chemiluminescence or fluorescence

  • Expected outcome: Identification of linear epitopes with 5-10 amino acid resolution

• Recombinant fragment analysis:

  • Express different domains of HXT10 as fusion proteins

  • Test antibody binding by Western blot and ELISA

  • Particularly useful for conformational epitopes that may not be detected in peptide arrays

• Alanine scanning mutagenesis:

  • For known binding regions, systematically replace individual amino acids with alanine

  • Express mutants in yeast and test antibody binding

  • Identify critical residues for antibody recognition

  • Research example: Similar to study where amino acids 24-30 were identified as critical for antibody recognition

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

  • Compare deuterium uptake patterns of HXT10 in the presence and absence of antibody

  • Protected regions indicate antibody binding sites

  • This advanced technique can resolve conformational epitopes with high precision

Research on antibody epitope mapping has demonstrated that even closely related antibodies may recognize distinct epitopes. For example, antibody "clone 27" recognized a restricted region at the N-terminal part of a protein's globular domain, while "clone 34" recognized a larger region encompassing amino acids 20-30 . This differential recognition can affect experimental outcomes when studying protein conformational changes.

How should researchers interpret contradictory results from different HXT10 antibody clones?

When different HXT10 antibody clones produce contradictory results, systematic analysis is required to resolve discrepancies. Follow this methodological framework:

Step-by-step analytical approach:

• Epitope comparison analysis:

  • Determine if antibodies recognize different domains of HXT10

  • Different epitopes may be differentially accessible depending on protein conformation

  • Research example: In study , two antibodies recognizing adjacent epitopes showed different binding patterns during cell differentiation

• Experimental condition assessment:

  • Document all buffer components, particularly detergents that might affect membrane protein structure

  • Consider sample preparation differences (native vs. denatured conditions)

  • Check for post-translational modifications that might affect epitope accessibility

• Cross-reactivity evaluation:

  • Test antibodies against recombinant HXT isoforms to assess specificity

  • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

  • Expected outcome: Identification of potential off-target binding

• Conformational state analysis:

  • Some antibodies may preferentially recognize specific conformational states

  • Test antibodies under conditions known to alter protein conformation (e.g., different glucose concentrations)

  • Research shows membrane proteins can adopt different conformations based on their functional state

• Validation with orthogonal methods:

  • Confirm protein levels or localization using non-antibody methods (e.g., GFP tagging)

  • Use genetic approaches (knockout/knockdown) to confirm specificity

Understanding epitope recognition is critical for interpreting results. Research has shown that antibody recognition can be dramatically affected by protein conformation and interaction with biological molecules like DNA. For example, study demonstrated that "the N-terminal tail domain of the protein can influence the recognition of [the protein] by these antibodies when the protein interacts with DNA."

What are effective troubleshooting strategies for weak or absent signals when using HXT10 antibodies?

When HXT10 antibody applications yield weak or no signal, methodical troubleshooting is essential. Follow this systematic approach:

Comprehensive troubleshooting protocol:

• Expression level verification:

  • HXT10 is glucose-repressed, with expression decreasing 16-fold under high glucose conditions

  • Verify experimental conditions match expected expression profile

  • Consider using positive control samples with known high expression

• Sample preparation optimization:

  • For membrane proteins like HXT10, extraction method is critical

  • Test different detergents: Start with 1% Triton X-100, then try CHAPS or digitonin for gentler extraction

  • Include protease inhibitors to prevent degradation

  • Optimize protein:detergent ratios to prevent aggregation

• Antibody validation checks:

  • Verify antibody recognizes native vs. denatured forms appropriately

  • Test concentration range (typical working dilutions: 1:500-1:5000 for Western blot)

  • Check antibody storage conditions and avoid repeated freeze-thaw cycles

  • Consider using a protein like BSA (1-5%) to stabilize diluted antibody preparations

• Technical optimization table:

• Signal amplification strategies:

  • For Western blot: Use high-sensitivity ECL substrates or fluorescent secondary antibodies

  • For immunofluorescence: Consider tyramide signal amplification (TSA)

  • For ELISA: Implement biotin-streptavidin amplification system

Research demonstrates that optimizing extraction conditions is particularly important for membrane proteins like HXT10. In one study, changing from standard RIPA buffer to a gentler digitonin-based lysis preserved protein-protein interactions that were disrupted under harsher conditions .

How can HXT10 antibodies be used to study the protein's role in metabolic adaptation during stress conditions?

HXT10's glucose-repressed expression pattern suggests a specialized role in metabolic adaptation. Recent research indicates its involvement in stress responses, particularly during α-synuclein-induced toxicity . Advanced methodological approaches using HXT10 antibodies include:

Multi-dimensional experimental design:

• Dynamic protein localization analysis:

  • Time-course immunofluorescence microscopy during stress induction

  • Co-staining with organelle markers to track potential redistribution

  • Live-cell imaging using antibody fragments (if cell-permeable)

  • Expected outcome: Visualization of HXT10 trafficking between membrane domains during stress

• Protein interaction network mapping:

  • Antibody-based proximity labeling (BioID or APEX)

  • Compare interaction partners under normal vs. stress conditions

  • Quantitative proteomics to identify stress-specific interactions

  • Focus on interactions with metabolic regulators and stress-response proteins

• Post-translational modification profiling:

  • Immunoprecipitate HXT10 using validated antibodies

  • Analyze by mass spectrometry for phosphorylation, ubiquitination, etc.

  • Compare modification patterns between normal and stress conditions

  • Link modifications to functional changes in transport activity

• Stress resistance correlation studies:

  • Use HXT10 antibodies to quantify expression in various yeast strains

  • Correlate expression levels with stress resistance phenotypes

  • Example finding: Genipin treatment that alleviates α-synuclein toxicity upregulates HXT10

Recent studies have shown that treating yeast cells with genipin led to "the upregulation of genes encoding for glucose (HXT10) and glycerol (GUP2) transporters" in a model of proteotoxic stress . This finding suggests HXT10's potential involvement in stress adaptation pathways beyond its classical role in glucose transport.

What are the methodological considerations for using HXT10 antibodies in comparative studies across different yeast species?

Using HXT10 antibodies for cross-species studies requires careful methodological planning to ensure valid comparisons. Follow these research strategies:

Cross-species experimental design:

• Epitope conservation analysis:

  • Perform sequence alignment of HXT10 orthologs across target species

  • Select antibodies targeting highly conserved regions

  • Consider generating new antibodies against universal epitopes if needed

  • Research shows even small variations in epitope sequences can significantly impact antibody binding

• Species-specific validation protocol:

  • Test antibody reactivity against recombinant proteins from each species

  • Include knockout controls from each species when available

  • Establish species-specific dilution series to account for affinity differences

  • Document optimal working concentrations for each species

• Data normalization strategy:

  • Select appropriate housekeeping proteins conserved across target species

  • Consider dual detection methods (e.g., epitope tagging + antibody detection)

  • When comparing expression levels, use recombinant protein standards for absolute quantification

• Cross-species technical considerations:

  • Adjust cell wall digestion protocols for species with different cell wall compositions

  • Optimize lysis buffers for species-specific membrane composition differences

  • Consider differences in post-translational modifications across species

Research demonstrates that even highly conserved proteins may require species-specific optimization. In antibody development studies, humanization of antibodies revealed "several hot spots in the framework region that appear to affect antigen binding, and therefore should be considered in human germline selection" . Similarly, when studying yeast proteins across species, these subtle differences must be methodologically addressed.